1. Abdolsamadi, H., Goodarzi, M. T., Ahmadi Motemayel, F., Jazaeri, M., Feradmal, J., Zarabadi, M., Hoseyni, M., & Torkzaban, P. (2014). Reduction of melatonin level in patients with type 2 diabetes and periodontal diseases. Journal of Dental Research Dental Clinics Dental Prospects, 8, 160–165.
2. Abikshyeet, P., Ramesh, V., & Oza, N. (2012). Glucose estimation in the salivary secretion of diabetes mellitus patients. Diabetes, Metabolic Syndrome and Obesity, 5, 149–154.
3. Ahmad, S. I. (2013). Introduction to Diabetes mellitus. Advances in Experimental Medicine and Biology, 771, 1–11. https://doi.org/10.1007/978-1-4614-5441-0_1
4. Aitken, J. P., Ortiz, C., Morales-Bozo, I., Rojas-Alcayaga, G., Baeza, M., Beltran, C., & Escobar, A. (2015). α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus. Disease Markers, 2015, 1. https://doi.org/10.1155/2015/128653
5. American Diabetes Association. (2009). Standards of medical care in diabetes: 2009. Diabetes Care, 32(Suppl 1), S13–S61.